ConductScience.org, home

Comparison · NCT04571684-71a67ac4

Intervention Arm (HITSystem 2.1) vs Control Arm (Standard of Care): Viral Suppression

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Intervention Arm (HITSystem 2.1) vs Control Arm (Standard of Care): Viral Suppression. Trial comparisons, record NCT04571684-71a67ac4. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT04571684-71a67ac4

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.9320.9110.948wilson
Risk in group 20.9210.8960.94wilson
Risk difference, group 1 minus group 20.0109-0.01770.0406newcombe hybrid score
Risk ratio, group 1 over group 21.010.9811.04log
Odds ratio, group 1 over group 21.170.7711.79log
Number needed to treat, for one more participant with the outcome on Intervention Arm (HITSystem 2.1) than on Control Arm (Standard of Care)91.8from the risk difference intervalthe interval includes no difference

Groups2

Group 2 names the comparator: standard of care.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Intervention Arm (HITSystem 2.1)
Participants enrolled at intervention sites will received HITSystem 2.1-supported PMTCT services through 6 months postpartum. Interventions received will include: text messages to patients to support medication adherence, appointment attendance, and hospital delivery and algorithm-driven alerts to notify providers when follow up services are missed.~HITSystem 2.1: HITSystem 2.1 is an intervention that tracks HIV+ pregnant women and their infants to improve the completeness and efficiency of PMTCT services. Key intervention features include: (1) SMS messages sent to enrolled women and mothers to support essential PMTCT services, (2) automated, algorithm-driven alerts for providers when per-guidelines PMTCT services are missed, and (3) automatic enrollment of infants into early infant diagnosis (EID) and linkage with maternal PMTCT file at documentation of infant birth to improve the continuum of care for HIV+ mothers and HIV-exposed infants. The HITSystem 2.1 intervention aims to facilitate complete PMTCT retention and viral load (VL) monitoring with prompt clinical action (adherence support, antiretroviral therapy (ART) regimen change) in the antenatal, delivery, and 6-month postpartum periods to increase viral suppression during windows critical for HIV prevention.
655703OG000
Group 2Control Arm (Standard of Care)Participants enrolled at control sites will receive standard of care PMTCT services, with no HITSystem 2.1 tracking or follow up.535581OG001

Outcome

Type
PRIMARY
Title
Viral Suppression
Description
Number of clients with a suppressed viral load(\<1000 copies/mL) at delivery
Time frame
1-9 months
Population
The overall number of participants analyzed include only those who had a documented viral load test at delivery.

Source ClinicalTrials.gov

Trial

Title
Evaluating HITSystem 2.1 to Improve Viral Suppression in Kenya
NCT number
NCT04571684
Phases
NA
Conditions
HIV, Pregnancy
Interventions
HITSystem 2.1
Lead sponsor
University of Kansas Medical Center
Results first posted
2025-07-10

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT04571684-71a67ac4